Sensorion
9 known investors
Find your way into Sensorion
Sign up to see every warm intro you have to Sensorion
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Sensorion team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Sensorion is a French clinical-stage biopharmaceutical company founded in 2009 in Montpellier that develops gene-therapy and small-molecule treatments for inner-ear disorders like genetic deafness and tinnitus.
Investors · 9
How we know: Sofinnova Partners's portfolio page · funding news · sofinnovapartners.com · Not right? Tell us
How we know: sofinnovapartners.com · Not right? Tell us
Also in the syndicate · 5
Funding
SEC filings, press & company announcements- Undisclosed amountreserved offeringJan 2026
Artal, Coastlands Capital, Cormorant Asset Management, Invus, Redmile Group, Sanofi, Sofinnova Partners, Sphera Healthcare
Source ↗ - Undisclosed amountReserved OfferingFeb 2024
Aquilo Capital, Invus, Redmile Group, Sofinnova Partners
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Sensorion do?
- Sensorion is a French clinical-stage biopharmaceutical company founded in 2009 in Montpellier that develops gene-therapy and small-molecule treatments for inner-ear disorders like genetic deafness and tinnitus.
- Who are Sensorion's investors?
- Sensorion's investors include Sofinnova Partners, Invus, REDMILE, Sanofi Ventures.


